Milan, Italy

Massimo Cini


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Location History:

  • Lainate, IT (1999)
  • Milan, IT (2000 - 2001)

Company Filing History:


Years Active: 1999-2001

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Mind of Massimo Cini

Introduction

Massimo Cini is an accomplished inventor based in Milan, Italy, recognized for his contributions to the field of pharmaceuticals. With a total of three patents to his name, he has carved a niche for himself through his innovative research and development efforts.

Latest Patents

Cini's latest patents include groundbreaking work on N-substituted-2-amino-4-phenyl-4-oxo-butanoic acid compounds, specifically focusing on their kynurenine-3-hydroxy base inhibitory activity. Another notable patent is the recombinant kynurenine-3-hydroxylase enzyme, showcasing his dedication to advancing medical sciences through innovative biochemistry.

Career Highlights

Currently, Massimo Cini is employed at Pharmacia & Upjohn S.p.a., where he plays a significant role in the research and development department. His work has not only propelled the company's reputation forward but has also paved the way for potential breakthroughs in drug development and therapeutic applications.

Collaborations

At Pharmacia & Upjohn S.p.a., Cini collaborates with talented professionals, including Carmela Speciale and Mario Varasi. These collaborations highlight the synergy within the team, driving forward innovative solutions in pharmaceuticals and fostering an environment conducive to cutting-edge research.

Conclusion

Massimo Cini's journey as an inventor reflects his commitment to innovation in the pharmaceutical industry. His patents and collaborations demonstrate a significant impact on research that aims to improve healthcare outcomes. As he continues to advance his work, Cini remains a noteworthy figure in the realm of inventions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…